Michael Jacobsen
Direttore Finanziario/CFO presso OMEROS CORPORATION
Patrimonio netto: 47 040 $ in data 31/05/2024
Profilo
Michael A.
Jacobsen is currently the Chief Accounting Officer, Treasurer & VP at Omeros Corp.
He previously worked as the Senior Director-Finance & Corporate Controller at ICOS Corp.
and as the Chief Accounting Officer & Vice President at ZymoGenetics, Inc. He also served as the Secretary, Chief Accounting Officer & VP-Finance at Sarepta Therapeutics, Inc. from 2012 to 2013.
Jacobsen received his undergraduate degree from Idaho State University in 1980.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
OMEROS CORPORATION
0.02% | 25/04/2024 | 14 000 ( 0.02% ) | 47 040 $ | 31/05/2024 |
Posizioni attive di Michael Jacobsen
| Società | Posizione | Inizio |
|---|---|---|
| OMEROS CORPORATION | Direttore Finanziario/CFO | 01/08/2013 |
Precedenti posizioni note di Michael Jacobsen
| Società | Posizione | Fine |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 15/11/2011 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Direttore operativo | 01/08/2011 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Direttore Finanziario/CFO | - |
Formazione di Michael Jacobsen
| Idaho State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| OMEROS CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
- Borsa valori
- Insiders
- Michael Jacobsen
